Submitted by Anonymous (not verified) on 13 September 2023 - 10:11
Opinion/decision on a Paediatric investigation plan (PIP): N-(6-(((2R,3S)-3,4-dihydroxybutan-2-yl)oxy)-2-((4-fluorobenzyl)thio)pyrimidin-4-yl)-3-methylazetidine-1-sulfonamide (RIST-4721), decision type: , therapeutic area: , PIP number: P/0275/2022
Source: